Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates

Bioorganic & Medicinal Chemistry Letters
2008.0

Abstract

The esterase, phosphatase, and sulfatase activities of carbonic anhydrase (CA, EC 4.2.1.1) isozymes, CA I, II, and XIII with 4-nitrophenyl esters as substrates was investigated. These enzymes show esterase activity with 4-nitrophenyl acetate as substrate, with second order rate constants in the range of 753-7706M(-1)s(-1), being less effective as phosphatases (k(cat)/K(M) in the range of 14.89-1374.40M(-1)s(-1)) and totally ineffective sulfatases. The esterase/phosphatase activities were inhibited by sulfonamide CA inhibitors, proving that the zinc-hydroxide mechanism responsible for the CO(2) hydrase activities of CAs is also responsible for their esterase/phosphatase activity. CA XIII was the most effective esterase and phosphatase. CA XIII might catalyze other physiological reactions than CO(2) hydration, based on its relevant phosphatase activity.

DOI： 10.1016/j.bmcl.2008.03.012

Knowledge Graph

Similar Paper

Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates
Bioorganic & Medicinal Chemistry Letters 2008.0
Paraoxon, 4-nitrophenyl phosphate and acetate are substrates of α- but not of β-, γ- and ζ-carbonic anhydrases
Bioorganic & Medicinal Chemistry Letters 2010.0
Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions
Bioorganic & Medicinal Chemistry Letters 2004.0
Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition
Bioorganic & Medicinal Chemistry Letters 2013.0
Carbonic anhydrases as targets for medicinal chemistry
Bioorganic & Medicinal Chemistry 2007.0
Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives
European Journal of Medicinal Chemistry 2011.0
Carbonic anhydrase activators: Activation of isozyme XIII with amino acids and amines
Bioorganic & Medicinal Chemistry Letters 2006.0
Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII
European Journal of Medicinal Chemistry 2010.0
Carbonic anhydrase inhibitors. Inhibition studies of the human secretory isoform VI with anions
Bioorganic & Medicinal Chemistry Letters 2007.0
Carbonic anhydrase activators: Activation of human isozymes I, II and IX with phenylsulfonylhydrazido l-histidine derivatives
Bioorganic & Medicinal Chemistry Letters 2009.0